KAISA LUOSTARI
Early Stage Researcher
Contact info
Organization
School of Medicine, Institute of Clinical Medicine
kaisa.luostari@uef.fi
Phone
+358 40 355 3093
Research groups - UEF
Publications
-
Pelkonen Mikko, Luostari Kaisa, Tengström Maria, Ahonen Hermanni, Berdel Bozena, Kataja Vesa, Soini Ylermi, Kosma Veli-Matti, Mannermaa Arto. 2015. Low expression levels of hepsin and TMPRSS3 are associated with poor breast cancer survival. BMC CANCER [ONLINE: HTTP://WWW.BIOMEDCENTRAL.COM/BMCCANCER/] 15 431: -. 2015
-
Luostari Kaisa, Hartikainen Jaana M, Tengström Maria, Palvimo Jorma J, Kataja Vesa, Mannermaa Arto, Kosma Veli-Matti. 2014. Type II Transmembrane Serine Protease Gene Variants Associate with Breast Cancer. PLOS ONE [ONLINE] 9 7: e102519. 2014
-
Tuomarila M, Luostari K, Soini Y, Kataja V, Kosma VM, Mannermaa A. 2014. Overexpression of MicroRNA-200c Predicts Poor Outcome in Patients with PR-Negative Breast Cancer. PLOS ONE [ONLINE] 9 10: e109508: 1-8. 2014
-
Malinen M, Jääskeläinen T, Pelkonen M, Heikkinen S, Väisänen S, Kosma VM, Nieminen K, Mannermaa A, Palvimo JJ. 2012. Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors Molecular and cellular endocrinology 2013; 365 2: 270-276. 2012